Transcatheter Heart Valve Replacement Technologies 2012 Facility and Physician Billing Guide
Transcatheter Heart Valve
For Physicians
Product Overview
Transfemoral System Components
The PARTNER Trial: Cohort B Results (NEJM)
Important Risk Information
Learn More
The PARTNER Trial
The PARTNER II Trial
Request Information

For Patients
Heart Basics
Treatment Options
Product Information
Patient Stories

Reimbursement


2012 Facility and Physician Billing Guide

Transcatheter Heart Valve Replacement Technologies



This guide is intended to support diagnostic and procedural coding for transcatheter aortic valve replacement (TAVR) procedures.
PDF download of Vascular Products 2011 Hospital and Physician Billing Guide  View the PDF version

HCPCS C Code Finder to search by model number

Contact Us with Reimbursement Questions
PHYSICIAN INPATIENT CODING
Clinicians use Current Procedural Terminology (CPT1)Category III codes to track the use of emerging technology, services, and procedures for clinical efficacy, utilization and outcomes, and to facilitate billing. Category III codes are temporary and do not have relative value units (RVUs) assigned to them unlike the "permanent" CPT Category I codes. Payment has not been established and is therefore based on the payers' policies rather than a yearly fee schedule.
The below procedure was assigned a Category III CPT code in July 2010 with an effective date of January 1, 2011.


Procedure

CPT Code1,2

Description

TAVR - transfemoral approach 

0256T
Modifiers that
may be allowed:
assistants at
surgery
-80
-81
-82

Implantation of catheter-delivered prosthetic
aortic heart valve; endovascular approach.

Code 0256T does not include cardiac catheterization
[93451-93572] when performed at the
time of the procedure for diagnostic purposes
prior to aortic valve replacement. Code 0256T
includes all other catheterization[s], temporary
pacing, intraprocedural contrast injection[s],
fluoroscopic radiological supervision and interpretation,
and imaging guidance, which are not
reported separately when performed to complete
the aortic valve procedure.



HOSPITAL INPATIENT DIAGNOSIS AND PROCEDURE CODING
Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnostic-Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. The following codes generally describe diagnosis and procedures associated with the use of the Edwards SAPIEN transcatheter heart valve technologies.

ICD9-CM3 Procedure Code

Description

424.1

Aortic valve disorders

39.49

Other revisions of vascular procedure


ICD9-CM3 Procedure Code

Description

35.054

Endovascular replacement of aortic valve

Cardiac Catheterization

The cardiac catheterization may be coded when performed for specific evaluation beyond the approach during the procedure.

MS_DRG5

Description

216

Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with MCC

217

Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with CC

218

Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization without MCC or CC

219

Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization with MCC

220

Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization with CC

221

Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization without MCC or CC


KEY CONTACTS

 
Joan Sunderland   Senior Regional Manager, Reimbursement
IA, ID, IN, KS, KY, MI, MN, MO, MT, NE, ND, OH, OR, PA (Pittsburgh only), SD, WA, WI, WV and WY

(949) 250-4029
joan_sunderland@edwards.com

Todd Davis   Senior Regional Manager, Reimbursement
AK, AR, AZ, CA, CO, HI, NM, NV, OK, TX and UT
(949) 250-4829
todd_davis@edwards.com
John Rader   Senior Regional Manager, Reimbursement
AL, DC, DE, FL, GA, LA, MD, MS, NC, SC, TN and VA

(407) 791-4369
john_rader@edwards.com

Heidi Myers   Senior Regional Manager, Reimbursement
CT, IL, MA, ME, NH, NJ, NY, PA (except Pittsburgh), RI and VT
(773) 636-2747
heidi_myers@edwards.com


Reference
1. Current Procedure Terminology (CPT) copyright 2011, American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/ DFARS restrictions apply to government use.
2. Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences' Transcatheter Heart Valve technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient's clinical presentation. When diagnostic services are performed, it may be appropriate to add applicable codes according to the service provided following the correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
3. International Classification of Diseases, 9th Revision, Clinical Modification 6th Edition, 2011 ICD-9-CM for hospitals, volume 1, 2, & 3.
4. Centers for Medicare & Medicaid Services (CMS). Updates and Revisions to ICD-9-CM Procedure Codes (Addendum). FY 2012 Medicare Addendum, ICD-9-CM Volume-3, Procedures. 26 October 2011. <http://www.cms.gov/icd9providerdiagnosticcodes/04_addendum.asp> and <http://www.cms.gov/ICD9ProviderDiagnosticCodes/Downloads/FY2012_Addenda.pdf>.
5. DRG Expert: A Comprehensive Guidebook to the DRG Classification System, 28th Edition, 2012.
CAUTION: Federal (United States) law restricts the Edwards SAPIEN transcatheter heart valve to sale by or on the order of a physician. This device has been approved by the FDA for specific indications for use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

DISCLAIMER
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
Contact Us | Legal Terms | Privacy Policy | © 2012 Edwards Lifesciences LLC. All rights reserved.